Republic of the Philippines
Department of Health
OFFICE OF THE SECRETARY
<doctype>ADMINISTRATIVE ORDER</doctype>
<date>04/11/2016</date>
<docnum>No. 2015 - 051A </docnum>
<subject>Subject: Amendment to ANNEX A of Administrative Order No. 2015 — 0051  regarding the Implementation of the Philippine Drug Price Reference Index (DPRI) to all Public Hospitals and Facilities. </subject>
<body>

Annex A, table 1, Column 4 (Brand Name) and Column 5 (Manufacturer), and table 2, 1st paragraph and Column 5 (Manufacturer) of Administrative Order No. 2015 — 0051 entitled “Guidelines in the Implementation of the Philippine Drug Price Reference Index (DPRI) to All Public Hospital and Health Facilities” presents examples distinct to actual facts and conﬂicting to the latter’s guidelines that may perplex the public. Hence, Annex A is hereby amended as follows: 

Table 1. 

For drugs with four (4) or more manufacturers, .the reference price is set at the median of the range of prices collected for every drug preparation and formulation. 

Paracetamol 500mg Tablet 

<image>table_1.png</image>

Note: The above table is an example and does not reﬂect the actual procurement data of the hospitals. 

Table 2. 

For drugs with three (3) or less manufacturers, the reference price is set at the lowest procured price. 

Amoxicillin 500mg Capsule 

<image>table_2.png</image>

Note: The above table is an example and does not reﬂect the actual procurement data of the hospitals. 

All other provisions of the Administrative Order No. 2015 — 0051 shall remain in effect and provisions / issuances inconsistent or contrary to this Order are hereby rescinded or modiﬁed accordingly. 

This Order shall take effect immediately. 

</body>

<sign>JANETTE P. LORETO-GARIN, M.D., MBA-H</sign>
<signtitle>Secretary of Health</signtitle>
 

